Cargando…
Secretome as a Tool to Treat Neurological Conditions: Are We Ready?
Due to their characteristics, mesenchymal stem cells (MSCs) are considered a potential therapy for brain tissue injury or degeneration. Nevertheless, despite the promising results observed, there has been a growing interest in the use of cell-free therapies in regenerative medicine, such as the use...
Autores principales: | da Silva, Andreia Valente, Serrenho, Inês, Araújo, Beatriz, Carvalho, Alexandre Martins, Baltazar, Graça |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671352/ https://www.ncbi.nlm.nih.gov/pubmed/38003733 http://dx.doi.org/10.3390/ijms242216544 |
Ejemplares similares
-
Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation: a systematic review
por: Ferreira, Susana A., et al.
Publicado: (2023) -
Hypothermia Does Not Boost the Neuroprotection Promoted by Umbilical Cord Blood Cells in a Neonatal Hypoxia-Ischemia Rat Model
por: Serrenho, Inês, et al.
Publicado: (2022) -
Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
por: Serrenho, Inês, et al.
Publicado: (2021) -
Are We Ready for Cell Therapy to Treat Stroke?
por: Rascón-Ramírez, Fernando José, et al.
Publicado: (2021) -
Are we ready?()
por: Pedrosa, C.
Publicado: (2020)